Trevi Therapeutics to Host Conference Call and Webcast on March 10th to Share Topline Results from the Phase 2a RIVER Trial of Haduvio in Patients with Refractory Chronic Cough



[
Trevi Therapeutics to Host Conference Call and Webcast on March 10th to Share Topline Results from the Phase 2a RIVER Trial of Haduvio in Patients with Refractory Chronic Cough
[og_img]
https://www.investing.com/news/press-releases/trevi-therapeutics-to-host-conference-call-and-webcast-on-march-10th-to-share-topline-results-from-the-phase-2a-river-trial-of-haduvio-in-patients-with-refractory-chronic-cough-93CH-3916591


Investing.com

Latest articles

spot_imgspot_img

Related articles

spot_imgspot_img